Trial
NCT05469178
A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
BerGenBio ASA
Collaborators
—
Condition
Carcinoma, Non-Small-Cell Lung
Intervention
Bemcentinib
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-29